Author:
Bowen R L,Duffy S W,Ryan D A,Hart I R,Jones J L
Publisher
Springer Science and Business Media LLC
Reference36 articles.
1. Adebamowo CA, Adekunle OO (1999) Case–controlled study of the epidemiological risk factors for breast cancer in Nigeria. Br J Surg 86: 665–668
2. Albain K, Unger JM, Hutchins LF, Rivkin SE, Martino S, Livingston RB, Osborne CK (2003) Outcome of African Americans on Southwest Oncology Group (SWOG) Breast Cancer Adjuvant Therapy Trials (abstr 21) San Antonio Breast Cancer Symposium. San Antonio, TX
3. Bhattacharyya A, Ear US, Koller BH, Weichselbaum RR, Bishop DK (2000) The breast cancer susceptibility gene BRCA1 is required for subnuclear assembly of Rad51 and survival following treatment with the DNA cross-linking agent cisplatin. J Biol Chem 275: 23899–23903
4. Bickell NA, Wang JJ, Oluwole S, Schrag D, Godfrey H, Hiotis K, Mendez J, Guth AA (2006) Missed opportunities: racial disparities in adjuvant breast cancer treatment. J Clin Oncol 24: 1357–1362
5. Brawley OW (2002) Disaggregating the effects of race and poverty on breast cancer outcomes. J Natl Cancer Inst 94: 471–473
Cited by
125 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献